Twin Tree Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-594
| Closed | -$31.4K | – | 1528 |
|
|
2026
Q1 | $32.8K | Buy |
+594
| New | +$32.2K | ﹤0.01% | 1205 |
|
|
2025
Q2 | – | Sell |
-93,813
| Closed | -$3.58M | – | 1752 |
|
|
2025
Q1 | $3.63M | Sell |
93,813
-89,615
| -49% | -$3.28M | 0.01% | 997 |
|
|
2024
Q4 | $6.2M | Buy |
+183,428
| New | +$6.6M | 0.01% | 863 |
|
|
2024
Q1 | – | Sell |
-32,980
| Closed | -$1.36M | – | 1415 |
|
|
2023
Q4 | $1.22M | Buy |
+32,980
| New | +$1.18M | ﹤0.01% | 1125 |
|
|
2022
Q3 | – | Sell |
-4,696
| Closed | -$178K | – | 1457 |
|
|
2022
Q2 | $256K | Sell |
4,696
-73,910
| -94% | -$4.08M | ﹤0.01% | 1336 |
|
|
2022
Q1 | $4.28M | Sell |
78,606
-325,554
| -81% | -$17.7M | 0.01% | 974 |
|
|
2021
Q4 | $22.3M | Buy |
+404,160
| New | +$21M | 0.05% | 374 |
|
|
2021
Q2 | – | Sell |
-37,243
| Closed | -$1.66M | – | 1455 |
|
|
2021
Q1 | $1.66M | Sell |
37,243
-53,753
| -59% | -$2.44M | 0.01% | 890 |
|
|
2020
Q4 | $4.19M | Buy |
90,996
+53,235
| +141% | +$2.45M | 0.02% | 672 |
|
|
2020
Q3 | $1.78M | Buy |
37,761
+11,973
| +46% | +$600K | 0.01% | 786 |
|
|
2020
Q2 | $1.31M | Buy |
+25,788
| New | +$1.32M | 0.01% | 987 |
|
|
2020
Q1 | – | Sell |
-19,447
| Closed | -$1.04M | – | 1463 |
|
|
2019
Q4 | $1.14M | Buy |
+19,447
| New | +$1.08M | ﹤0.01% | 835 |
|
|
2018
Q3 | – | Sell |
-13,124
| Closed | -$667K | – | 1143 |
|
|
2018
Q2 | $661K | Sell |
13,124
-2,319
| -15% | -$117K | ﹤0.01% | 857 |
|
|
2018
Q1 | $754K | Buy |
+15,443
| New | +$719K | 0.01% | 717 |
|
|
2017
Q2 | – | Sell |
-32,541
| Closed | -$1.72M | – | 1027 |
|
|
2017
Q1 | $1.72M | Buy |
+32,541
| New | +$1.65M | 0.02% | 598 |
|
|
2015
Q4 | – | Sell |
-5,617
| Closed | -$286K | – | 1461 |
|
|
2015
Q3 | $270K | Sell |
5,617
-8,295
| -60% | -$432K | 0.01% | 933 |
|
|
2015
Q2 | $724K | Sell |
13,912
-2,413
| -15% | -$136K | 0.02% | 737 |
|
|
2015
Q1 | $942K | Sell |
16,325
-13,660
| -46% | -$783K | 0.02% | 600 |
|
|
2014
Q4 | $1.6M | Buy |
29,985
+13,139
| +78% | +$735K | 0.04% | 450 |
|
|
2014
Q3 | $968K | Buy |
16,846
+14,902
| +767% | +$914K | 0.03% | 575 |
|
|
2014
Q2 | $130K | Sell |
1,944
-16,258
| -89% | -$1.1M | ﹤0.01% | 823 |
|
|
2014
Q1 | $1.22M | Buy |
+18,202
| New | +$1.23M | 0.02% | 576 |
|
Other funds holding GSK
JEST
Twin Tree Management's GSK Position: Q2 2026 in Review
Twin Tree Management sold out of GSK (GSK) in Q2 2026, closing a stake of 594 shares — an estimated $31.4K sold.
Twin Tree Management first reported a position in GSK in Q1 2014 and held it in 22 quarters. The position peaked at $22.3M in Q4 2021. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.
- Twin Tree Management reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
- Twin Tree Management sold 594 GSK shares in Q2 2026, an estimated $31.4K.
- Twin Tree Management first reported a position in GSK in Q1 2014 and held it in 22 quarters.
- Twin Tree Management's GSK position peaked at $22.3M in Q4 2021.
- 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.
Based on Twin Tree Management's 13F filing for Q2 2026, filed 12 Aug 2026.